中山医学院药理学教研室,2.中山医学院心血管研究群体,广东,广州,510080
网络首发:2017-03-16,
纸质出版:2017
移动端阅览
王冠蕾. 囊性纤维化跨膜转导调节因子(CFTR)氯通道对 心血管功能影响的研究进展[J]. 中山大学学报(医学科学版), 2017,38(2).
CFTR in Cardiovascular Functions[J]. Journal of Sun Yat-sen University (Medical Sciences), 2017, 38(2).
囊性纤维化跨膜转导调节因子(CFTR)是一类ATP门控、cAMP依赖激活的氯离子通道,其基本生理功能是调 控氯离子分泌与跨膜物质转运。CFTR基因突变导致囊性纤维化(CF)的发生,这是一种罕见却致命的常染色体隐性遗传疾 病,主要影响呼吸道、肠道和生殖系统腺上皮功能。现已有针对CF单基因突变的新药上市,这些药物显著改善CF患者呼 吸道症状,延长患者生命和改善生活质量。CFTR研究多聚焦于上述CF相关系统,在心血管系统的作用尚未清楚。CFTR 参与血管收缩和心肌动作电位形成,近来研究提示CFTR参与心肌缺血和肺动脉高压等心血管疾病的发生发展。
Cystic fibrosis transmembrane conductance regulator(CFTR)is an ATP-gated,cAMP-dependent chloride channel. The basic biophysical and pathological functions of CFTR are related with the secretion of chloride ion in epithelial cells and tissues. Mutations in CFTR cause cystic fibrosis(CF),which is a rare but fatal autosomal recessive inheritant disease,mainly affecting glan? dular epithelial function in respiratory tract,intestinal and reproductive system. New drugs targeting human CFTR gene mutations have been developed to significantly prolong lifeand improve respiratory symptoms of CF patients. Recent evidence suggested that CFTR plays a functional role in vasoconstriction and the formation of myocardial action potential. As a channel protein,CFTR may al? so functions as a multiprotein/channel complex,which has been demonstrated in the development of cardiovascular diseases such as myocardial ischemia and pulmonary hypertension.
0
浏览量
754
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
